lobbying_activities: 1129756
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1129756 | a67d678f-3c83-45ec-80cd-55931984befa | Q2 | THE UNITED STATES PHARMACOPEIAL CONVENTION | 400358632 | THE UNITED STATES PHARMACOPEIAL CONVENTION | 2011 | second_quarter | PHA | - Advise on standards-setting, verification, overseas programs, and quality of medicines activities related to drugs, dietary supplements, biologics and food ingredients. - H.R. 1483, "Drug Safety Enhancement Act of 2011", regarding Section 102 on drug supply quality and safety. - H.R. 2227, "Medical Gas Safety Act", regarding Section 3, Regulation of Medical Gases. - H. 2112, "Agriculture Appropriations Bill, FY 2012", regarding support for FDA funding. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Government Accountability Office (GAO),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),SENATE | 60000 | 0 | 0 | 2011-07-20T11:34:24.487000-04:00 |